期刊文献+

丹丽心脉通胶囊质量标准的研究 被引量:2

Dan li Xin Mai Tong Capsule Quality Criteria
原文传递
导出
摘要 目的对丹丽心脉通胶囊的显微特征、薄层色谱鉴别进行试验,为制订丹丽心脉通胶囊的质量标准提供研究方法。方法通过显微镜观察丹丽心脉通胶囊中黄连、枳壳、高丽参的显微特征;采用薄层色谱鉴别丹丽心脉通胶囊中丹参、黄连。结果丹丽心脉通胶囊的显微特征易见、专属;薄层色谱所得色谱斑点清晰,供试品色谱在与对照药材和对照品色谱相应位置上斑点对应良好,且阴性无干扰。结论该方法稳定、可靠,可应用于控制丹丽心脉通胶囊的质量。 Objective To test Dan li xin tong capsule of arteries and veins of microscopic characteristics,TLC identification test,to provide the research methods for the development of Dan li heart pulse tong capsule quality standard.Methods Through a microscope Dan li heart arteries and veins,bitter orange,rhizoma coptidis in tong capsule ginseng microscopic characteristics;The TLC was used Dan li heart arteries and veins through salvia miltiorrhiza,rhizoma coptidis capsules.Results Dan li xin tong capsule of arteries and veins of microscopic characteristic is easy to see,exclusive;TLC the chromatographic spots were clear,chromatography to the control of the test and reference substance chromatography spots corresponding to the corresponding position is good,and the negative no interference. Conclusion The method is stable,reliable and can be applied to control Dan li xin tong pulse capsule quality.
出处 《中国药物经济学》 2014年第5期12-13,共2页 China Journal of Pharmaceutical Economics
关键词 显微 薄层色谱 质量 Microscopic Thin layer chromatography Quality
  • 相关文献

参考文献2

二级参考文献22

  • 1Yuan R,Lin Y.Traditional Chinese medicine:an approach to scientific proof and clinical validation[J].Pharmacol Therap,2000,86:191-198.
  • 2Wang Z G,Ren J.Current status and future direction of Chinese herbal medicine[J].Trends Pharmacol Sci,2002,23(8):347-348.
  • 3Chan K.Progress in traditional Chinese medicine[J].Trends Pharmacol Sci,1995,16:182-187.
  • 4Bai D L.Traditional Chinese medicine and new drug development[J].Pure Appl Chem,1993,65(6):1103-1112.
  • 5McRae C A,Agarwald K,Multimer D,et al.Hepatitis associated with Chinese herbs[J].Eur J Gastroenterol Hepatol,2002,14(5):559-562.
  • 6Charles A M,Avorn J.Internet marketing of herbal products[J].JAMA,2003,290(11):1505-1509.
  • 7Dobos G J,Tana L,Cohen M H,et al.Are national quality standards for traditional Chinese herbal medicine sufficient?Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country[J].Compl Therap Med,2005,13;183-190.
  • 8Ferguson J E,Chalmers R J G,Rowlands D J.Reversible dilitated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine[J].Br J Dermatol,1997,136:592-593.
  • 9Nortier J L,Martinez M C,Schmeiser H H,et al.Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)[J].N Engl J Med,2000,342(23):1686-1692.
  • 10Pach D,Willich S N,Becker W C.Acailability of research results on traditional Chinese pharmacology[J].Forsch Komp Klas Nat,2002,9:352-358.

共引文献13

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部